Literature DB >> 9315556

Selective modulation of inducible nitric oxide synthase isozyme in myocardial infarction.

S M Wildhirt1, H Suzuki, D Horstman, S Weismüller, R R Dudek, K Akiyama, B Reichart.   

Abstract

BACKGROUND: Inducible nitric oxide synthase (iNOS) is activated in cardiac disorders. We investigated the contribution of increased iNOS activity to the development of left ventricular dysfunction after myocardial infarction by selective inhibition of the isozyme. METHODS AND
RESULTS: Male New Zealand rabbits were subjected to myocardial infarction. Animals were treated with either saline, S-methylisothiourea sulfate (SMT) (a selective iNOS inhibitor), or N(omega)-nitro-L-arginine (L-NNA) (a nonselective NOS inhibitor). Inducible and constitutive NOS (cNOS) activity, plasma NO(x), cGMP, hemodynamics, and myocardial blood flow were measured before and 5, 24, and 72 hours after coronary occlusion. Infarction 72 hours after occlusion resulted in increased myocardial iNOS activity, increased cardiac NO(x) production, and elevated cGMP levels. cNOS remained unchanged. Infarction increased left ventricular end-diastolic pressure (LVEDP) and decreased maximum +dP/dt and -dP/dt. L-NNA inhibited iNOS and cNOS activities and plasma NO(x) levels. L-NNA further increased LVEDP and reduced myocardial blood flow. Administration of SMT 72 hours after infarction significantly inhibited iNOS and cardiac NO(x) production but had no effects on cNOS. SMT improved left ventricular maximum +dP/dt and -dP/dt and decreased LVEDP. Myocardial blood flow in the remote myocardium increased.
CONCLUSIONS: These findings suggest that induction of iNOS activity 72 hours after infarction exerts negative inotropic effects and contributes to the development of myocardial dysfunction; selective modulation of increased iNOS activity by SMT improves cardiac performance, enhances myocardial blood flow, and may be beneficial in the treatment of acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9315556     DOI: 10.1161/01.cir.96.5.1616

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

1.  Regulation of nitric oxide consumption by hypoxic red blood cells.

Authors:  Tae H Han; Erion Qamirani; Allyson G Nelson; Daniel R Hyduke; Gautam Chaudhuri; Lih Kuo; James C Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-01       Impact factor: 11.205

2.  The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene.

Authors:  Y Guo; W K Jones; Y T Xuan; X L Tang; W Bao; W J Wu; H Han; V E Laubach; P Ping; Z Yang; Y Qiu; R Bolli
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

3.  Role of inducible nitric oxide synthase in myocardial ischemia-reperfusion injury in sleep-deprived rats.

Authors:  Sajad Jeddi; Asghar Ghasemi; Alireza Asgari; Amir Nezami-Asl
Journal:  Sleep Breath       Date:  2017-09-23       Impact factor: 2.816

4.  The role of iNOS-derived NO in the antihypertrophic actions of B-type natriuretic peptide in neonatal rat cardiomyocytes.

Authors:  Tiannan Wang; Ming Yan; Jieyue Li; Xiaoxiang Zheng
Journal:  Mol Cell Biochem       Date:  2007-05-09       Impact factor: 3.396

5.  Dead or alive? Autofluorescence distinguishes heat-fixed from viable cells.

Authors:  Leah Hennings; Yihong Kaufmann; Robert Griffin; Eric Siegel; Petr Novak; Peter Corry; Eduardo G Moros; Gal Shafirstein
Journal:  Int J Hyperthermia       Date:  2009-08       Impact factor: 3.914

6.  Significance of wine and resveratrol in cardiovascular disease: French paradox revisited.

Authors:  Ramesh Vidavalur; Hajime Otani; Pawan K Singal; Nilanjana Maulik
Journal:  Exp Clin Cardiol       Date:  2006

7.  The use of moderate hypothermia during cardiac surgery is associated with repression of tumour necrosis factor-alpha via inhibition of activating protein-1: an experimental study.

Authors:  Ma Qing; Michael Wöltje; Kathrin Schumacher; Magdalena Sokalska; Jaime F Vazquez-Jimenez; Ralf Minkenberg; Marie-Christine Seghaye
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

8.  The role of S-methylisothiourea hemisulfate as inducible nitric oxide synthase inhibitor against kidney iron deposition in iron overload rats.

Authors:  Maryam Maleki; Melika Samadi; Mehrangiz Khanmoradi; Mehdi Nematbakhsh; Ardeshir Talebi; Hamid Nasri
Journal:  Adv Biomed Res       Date:  2016-05-30

Review 9.  The Dual Role of Inducible Nitric Oxide Synthase in Myocardial Ischemia/Reperfusion Injury: Friend or Foe?

Authors:  Xin Yu; Liang Ge; Liang Niu; Xin Lian; Haichun Ma; Lei Pang
Journal:  Oxid Med Cell Longev       Date:  2018-10-28       Impact factor: 6.543

10.  Sabiporide reduces ischemia-induced arrhythmias and myocardial infarction and attenuates ERK phosphorylation and iNOS induction in rats.

Authors:  Henri Doods; Dongmei Wu
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.